Guidelines for Reporting Outcomes in Trial Protocols : vimar

This report, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)–Outcomes 2022 extension, is a consensus statement on the standards

Related Keywords

United States , Canada , Toronto , Ontario , Ottawa , America , Canadian , Pharma Gmb , Andrea Chiaramida , Robin Hayeems , Eli Lilly , Petros Pechlivanoglou , Lisa Stallwood , Amgen , Peter Gilgan Centre For Research , American College Of Rheumatology , Cundill Centre For Child , Analysis Methods Group , Pfizer , Astrazeneca , Health Sciences , Forest Pharmaceuticals , Vertex Pharmaceuticals , Takeda Pharmaceutical Co Ltd , Drug Administration , Sickkids Foundation , Canadian Institutes Of Health Research , Key Development Phases , Parexel International , National Health , Genentech , Mental Health , Novartis , Transparency Of Health Research , Canadian Cancer Society , Ottawa Hospital Academic Medical Organization , Research Manitoba , Td Bank Financial Group , Centre For Addiction , Ontario Ministry Of Health , Children Hospital Research Institute Of Manitoba , Bristol Myers Squibb , Research Council , Regeneron Pharmaceuticals , National Institute Of Health Research , Reformulary Group , Savient Pharmaceuticals , International Conference On Harmonisation , European League , Health Research , Standard Protocol Items , Interventional Trials , Cochrane Methodology Register , International Conference , Reporting Planned Endpoints , Clinical Trials , Enhancing Quality , Consolidated Standards , Reporting Trials , Development Phases , Section Ref , Terms Used , Checklist Items , Primary Outcome , Analysis Metric , Minimal Important Change , Outcome Data Collected Are Continuous , Will Be Analyzed , Cutoff Values , Outcome Assessments Will Be Performed , Several Time Points After Randomization , Time Points That Will Be Used , Composite Outcome Is Used , Define All Individual Components , Composite Outcome , Target Difference Between Treatment Groups , Minimal Important Difference , Difference Elicitation , Data Collection , What Is Known About , Study Instruments , Population Similar , Study Sample , Who Will Assess , Any Planned Methods , Secondary Outcomes , Coprimary Outcomes , Same Outcome Assessed , Multiple Time Points , Subgroup Analyses , North America , Peter Gilgan Centre , Sick Children , Interest Disclosures , Cundill Centre , Youth Depression , Canadian Institutes , Ontario Ministry , National Institute , Medical Research , Hospital Research Institute , Cochrane Prospective Meta Analysis Methods , Hoffmann La Roche , Horizon Therapeutics , American College , Treating Anxiety Disorders , Young Children , Financial Group , Executive Deputy Editor , Open Science Framework ,